Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

173

Figures (1-2)

Tables (1-3)

Sum=331

Publishing Process of This Article

Item

Count

Browse

Download

Sum=43

Mar 24, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Mar 24, 2025; 16(3): 101251
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101251

Full Size Figure Download Figure

Figure 1 Kaplan-Meier estimates of survival. A: Progression-free survival of the whole cohort; B: Overall survival of the whole cohort.

Citation: Wei ZJ, Wang L, Wang RQ, Wang Y, Chen H, Ma HL, Xu YJ. Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma. World J Clin Oncol 2025; 16(3): 101251
URL: https://www.wjgnet.com/2218-4333/full/v16/i3/101251.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i3.101251